Annotation Detail

Information
Associated Genes
PTPN11
Associated Variants
PTPN11 p.Phe285Leu (p.F285L) ( ENST00000351677.7, ENST00000392597.5, ENST00000635625.1, ENST00000639857.2, ENST00000687906.1, ENST00000688597.1, ENST00000690210.1 )
PTPN11 p.Phe285Val (p.F285V) ( ENST00000688597.1, ENST00000392597.5, ENST00000690210.1, ENST00000639857.2, ENST00000635625.1, ENST00000687906.1, ENST00000351677.7 )
PTPN11 p.Phe285Leu (p.F285L) ( ENST00000687906.1, ENST00000351677.7, ENST00000392597.5, ENST00000688597.1, ENST00000635625.1, ENST00000639857.2, ENST00000690210.1 )
PTPN11 p.Phe285Leu (p.F285L) ( ENST00000351677.7, ENST00000392597.5, ENST00000635625.1, ENST00000639857.2, ENST00000687906.1, ENST00000688597.1, ENST00000690210.1 )
PTPN11 p.Phe285Val (p.F285V) ( ENST00000351677.7, ENST00000392597.5, ENST00000635625.1, ENST00000639857.2, ENST00000687906.1, ENST00000688597.1, ENST00000690210.1 )
PTPN11 p.Phe285Leu (p.F285L) ( ENST00000351677.7, ENST00000392597.5, ENST00000635625.1, ENST00000639857.2, ENST00000687906.1, ENST00000688597.1, ENST00000690210.1 )
Associated Disease
Exanthema
Source Database
DisGeNET
Description
We suggest that the atypical severe symptoms in the index patient may be caused by an additive effect on the F285L mutation in PTPN11 by another mutation, for example the NF1 R1809C or alternatively, the not yet identified gene mutation associated with CAL spots in this family.
Pubmed
19120036
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.00108576748832121
Year of publication
2009
Drugs